Aeluma, INC

Aeluma, Inc. has signed a Letter of Intent with the U.S. Department of Commerce for up to $30 million in proposed funding under the CHIPS and Science Act to advance its scalable non-InP substrate technology for AI datacom.

Aeluma, Inc. has released an investor presentation detailing its advancements in Indium Gallium Arsenide (InGaAs) semiconductor manufacturing for next-generation photonics.

Aeluma, Inc. announced its third quarter fiscal 2026 financial results, highlighting significant contract wins totaling over $4 million and strategic partnerships to scale quantum dot laser technology.

Aeluma, Inc. has entered into a sales agreement with several agents to potentially sell up to $50 million of its common stock through an at-the-market offering.

Aeluma, Inc. announced its second quarter fiscal 2026 financial results, reporting $1.3 million in revenue and a GAAP net loss of $1.9 million, alongside new contract wins and strategic hires.

Aeluma, Inc. announced the results of its 2025 Annual General Meeting, where shareholders re-elected Class I directors and ratified the appointment of independent auditors.

Aeluma reports increased revenue and expanded R&D investment while addressing internal control deficiencies in its Q3 2026 10-Q filing.

Aeluma, Inc. reported increased revenue and a significant cash position following recent public offerings, despite a rise in operating expenses and an ineffective internal control environment.

Aeluma, Inc. reported significant revenue growth and a substantial capital raise, alleviating going concern doubts, despite an increased net loss driven by operational expansion.

Aeluma Inc. reports increased revenue and a successful public offering in Q3 2025, alleviating going concern doubts.

Aeluma Inc. reports a significant increase in revenue driven by government contracts, but also a widened net loss for the quarter ended December 31, 2024.

Aeluma Inc. saw a significant increase in revenue and a reduction in net losses for the quarter ended September 30, 2024, driven by government contracts and product sales, while also securing a major DARPA contract.

Aeluma, Inc. reported a significant 408% increase in revenue for fiscal year 2025, driven by government contracts, and successfully raised $12.6 million in net proceeds from a public offering, alleviating prior going concern doubts.

Aeluma Inc. reports a significant 375% increase in revenue for fiscal year 2024, driven by government contracts and product sales, while also highlighting ongoing losses and the need for additional capital.

Aeluma, Inc. Director and CEO Jonathan Klamkin sold a total of 18,900 shares of common stock on June 1, 2026, under a pre-arranged Rule 10b5-1 trading plan.

Director Steven Denbaars sold 25,000 shares of Aeluma, Inc. common stock via a pre-arranged Rule 10b5-1 trading plan.

Aeluma, Inc. CEO Jonathan Klamkin reported a series of stock transfers to a family trust and subsequent sales under a Rule 10b5-1 trading plan.

Jonathan Klamkin, CEO and Director of Aeluma, Inc., reported the sale of 20,000 common shares for approximately $261,940 under a pre-established Rule 10b5-1 trading plan.

Aeluma, Inc. CEO Jonathan Klamkin reported the sale of 50,000 shares of common stock on March 4, 2026, executed under a pre-arranged Rule 10b5-1 trading plan.

Aeluma, Inc. Director Craig H. Ensley was granted 10,633 shares of common stock as restricted stock units on December 3, 2025, increasing his direct beneficial ownership to 27,300 shares.

AELUMA, INC. announces its 2025 Annual Meeting of Stockholders to vote on the re-election of Class I directors and the re-appointment of independent auditors.

Aeluma, Inc. announces its 2025 Annual General Meeting of Shareholders to elect directors and ratify auditors, alongside reporting significant revenue growth and successful capital raises.

Aeluma Inc. has announced its 2024 Annual General Meeting of Shareholders to be held on January 9, 2025, to vote on the election of a Class III director and the reappointment of its independent auditors.

Aeluma, Inc. has filed a registration statement to offer an additional $1,300,000 in common stock and underwriter warrants.

Aeluma, Inc. has filed a pre-effective amendment to its Form S-1 registration statement, primarily related to exhibits and legal opinions concerning the offering of common stock and warrants.

Aeluma, Inc., a Delaware corporation specializing in optoelectronic and electronic devices, is undertaking a firm commitment underwritten public offering to raise capital and list its common stock on a national exchange.

Aeluma, Inc. is undertaking a firm commitment underwritten public offering to raise capital for business development, manufacturing advancements, and general corporate purposes, while also seeking a listing on a national exchange.

Aeluma, Inc. is seeking to raise capital through a public offering and NASDAQ uplisting to expand its business development, advance manufacturing processes, and for general working capital.

Former Aeluma, Inc. COO Lee McCarthy has significantly reduced his beneficial ownership in the company, now holding 1.5% of common stock.

BlackRock, Inc. has reported beneficial ownership of 5.3% of AELUMA INC's common stock as of June 30, 2026.

Mark N. Tompkins has filed an exit statement for Aeluma, Inc. after his beneficial ownership dropped below the 5% reporting threshold.

George Perry and boisei investments llc have disclosed a 5.6% beneficial ownership stake in Aeluma, Inc., holding 1,000,000 shares of common stock.

Mark N. Tompkins has reported an increased beneficial ownership of 15.99% in Aeluma, Inc.'s common stock, holding 2,856,833 shares.

AWM Investment Company, Inc. has filed an amended Schedule 13G, disclosing a reduced beneficial ownership of 2.6% in Aeluma, Inc.'s common stock as of May 30, 2025.

AWM Investment Company, Inc. has reported a beneficial ownership of 5.3% of Aeluma, Inc.'s common stock, totaling 825,000 shares, held across several of its managed funds.